A type of targeted chemotherapy developed by China-based Kelun-Biotech and licensed to Merck cut the risk of tumor ...

Preliminary results from Phase 1 data for LB2102 to reinforce early evidence of activity in solid tumors in a rapid oral ...

Biotech is increasingly financed, governed and regulated as though it were a mature pharmaceutical industry rather than a ...

The Food and Drug Administration is still in turmoil, but Wall Street no longer cares.

Biotech investors are once again rotating aggressively into clinical-stage growth stories as a fresh wave of capital ...

As FDA activity accelerates and big pharma searches for its next generation of blockbuster drugs, select biotech companies ...

Vir Biotechnology has a cash runway into 2028 and pivotal 2026 catalysts for its lead hepatitis drugs. Learn why VIR stock is ...

CHAPEL-EN-LE-FRITH, United Kingdom and SAN FRANCISCO, May 21, 2026 (GLOBE NEWSWIRE) -- Concept Life Sciences, a leading ...

Having unearthed the world’s largest triceratops head, Christian Angermayer knows where to find treasure among the dirt. Step forward Sunday’s inaugural ‘Steroid Olympics’ promoting PEDs to the masses ...

Ironwood Pharmaceuticals is rated a Buy after a 14.5% decline driven by the CFO's resignation and insider selling. Read more ...

Biotech’s ~10-year path from private risk to approved therapy is mismatched with trading-driven capital markets, where minor ...

A growing Ebola outbreak in central Africa has reignited investor interest in antiviral biodefence plays, helping lift shares ...